Unum Group (UNM) : Traders are bullish on Unum Group (UNM) as it has outperformed the S&P 500 by a wide margin of 2.07% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 3.15%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 3.09% in the last 1 week, and is up 5.49% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The stock has recorded a 20-day Moving Average of 5.15% and the 50-Day Moving Average is 0.22%. Unum Group has dropped 1.74% during the last 3-month period . Year-to-Date the stock performance stands at 2.21%.
Unum Group (NYSE:UNM): On Fridays trading session , Opening price of the stock was $33.38 with an intraday high of $33.75. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $33.23. However, the stock managed to close at $33.41, a loss of 0.48% for the day. On the previous day, the stock had closed at $33.57. The total traded volume of the day was 1,575,027 shares.
Unum Group is a provider of disability insurance products in the United States and the United Kingdom. The Companys business segments: Unum US, Unum UK, Colonial Life, Closed Block and Corporate. Unum US includes group long-term and short-term disability insurance, group life and accidental death and dismemberment products, and supplemental and voluntary lines of business. Unum UK includes insurance for group long-term disability, group life and lines of business, which include individual disability and critical illness products. Colonial Life includes insurance for accident, sickness, and disability products, life products, and cancer and critical illness products to employees. The Companys Closed Block segment consists of individual disability, group and individual long-term care, and other insurance products no longer actively marketed. Its Corporate segment includes investment income on corporate assets not specifically allocated to a line of business.